LungLife AI, Inc.
LungLife AI is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence.
Funding history
About LungLife AI, Inc.
How much funding has LungLife AI, Inc. raised?
LungLife AI, Inc. has raised $316K in total funding. The most recent round was Series B.
Where is LungLife AI, Inc. headquartered?
LungLife AI, Inc. is headquartered in Thousand Oaks, CA.
What does LungLife AI, Inc. do?
LungLife AI is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence.
What problem does LungLife AI, Inc. solve?
Lung cancer, described as the deadliest cancer globally, is often diagnosed too late (the page states 1 in 16 people in the US will be diagnosed in their lifetime).
What's LungLife AI, Inc.'s solution?
LungLife AI's LungLB test uses a minimally invasive blood draw to give clinicians additional information when evaluating indeterminate lung nodules.
What makes LungLife AI, Inc. different?
The test is run in the company's own CLIA-certified laboratory in Thousand Oaks, California, under its trademarked LiquidBiopsy technology.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.